IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:3387-3396.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0349

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, A. C.
Right arrow Articles by Skapek, S. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, A. C.
Right arrow Articles by Skapek, S. X.

Pathogenesis of Persistent Hyperplastic Primary Vitreous in Mice Lacking the Arf Tumor Suppressor Gene

Amy C. Martin,1 J. Derek Thornton,1 Jiewiu Liu,2 XiaoFei Wang,3,4,5 Jian Zuo,2 Monica M. Jablonski,3,4,5 Edward Chaum,3 Frederique Zindy,6 and Stephen X. Skapek1,3

1From the Departments of Hematology/Oncology, 6Genetics and Tumor Cell Biology, and 2Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee; and the 3Departments of Ophthalmology and 4Anatomy and Neurobiology and the 5Tennessee Mouse Genome Consortium, The University of Tennessee Health Science Center, Memphis, Tennessee.

PURPOSE. Persistent hyperplastic primary vitreous (PHPV) is an idiopathic developmental eye disease associated with failed involution of the hyaloid vasculature. The present work addressed the pathogenesis of PHPV in a mouse model that replicates many aspects of the human disease.

METHODS. Ophthalmoscopic and histologic analyses documented pathologic processes in eyes of mice lacking the Arf gene compared with Ink4a-deficient and wild-type control animals. Immunohistochemical staining, in situ hybridization, and RT-PCR demonstrated the expression of relevant gene products. Arf gene expression was determined by in situ hybridization using wholemounts of wild-type mouse eyes and by immunofluorescence staining for green fluorescent protein (GFP) in Arf+/GFP heterozygous knock-in mouse eyes.

RESULTS. Abnormalities in Arf–/– mice mimicked those found in patients with severe PHPV. The mice had microphthalmia; fibrovascular, retrolental tissue containing retinal pigment epithelial cells and remnants of the hyaloid vascular system; posterior lens capsule destruction with lens degeneration and opacity; and severe retinal dysplasia and detachment. Eyes of mice lacking the overlapping Ink4a gene were normal. Arf was selectively expressed in perivascular cells within the vitreous of the postnatal eye. Cells composing the retrolental mass in Arf–/– mice expressed the Arf promoter. The remnant hyaloid vessels expressed Flk-1. Its ligand, vascular endothelial growth factor (Vegf), was expressed in the retrolental tissue and the adjacent dysplastic neuroretina.

CONCLUSIONS. Arf–/– mice have features that accurately mimic severe PHPV. In the HVS, Arf expression in perivascular cells may block their accumulation or repress Vegf expression to promote HVS involution and prevent PHPV.





This article has been cited by other articles:


Home page
IOVSHome page
J. D. Thornton, D. J. Swanson, M. N. Mary, D. Pei, A. C. Martin, S. Pounds, D. Goldowitz, and S. X. Skapek
Persistent Hyperplastic Primary Vitreous Due to Somatic Mosaic Deletion of the Arf Tumor Suppressor
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
R B Bhisitkul
Vascular endothelial growth factor biology: clinical implications for ocular treatments.
Br. J. Ophthalmol., December 1, 2006; 90(12): 1542 - 1547.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. McGannon, Y. Miyazaki, P. C. Gupta, E. I. Traboulsi, and C. Colmenares
Ocular Abnormalities in Mice Lacking the Ski Proto-oncogene.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4231 - 4237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology